Anzeige
Mehr »
Login
Donnerstag, 23.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
287 Leser
Artikel bewerten:
(1)

Flowers Software GmbH: FLOWERS SOFTWARE SECURES $3.2 MILLION IN SEED TO BRING ENTERPRISE-GRADE WORKFLOW AUTOMATION TO SMBs

Finanznachrichten News

Startup Focuses on EU Market with Funding Led by La Famiglia VC

MUNICH, Nov. 2, 2022 /PRNewswire/ -- Flowers Software, an organizational management system that helps SMB companies improve their processes, announces today that it has raised $3.2 million in seed funding. The seed round was led by La Famiglia VC with participation from LEA Partners, Collective Ventures and angel investors including Personio's Co-Founder Ignaz Forstmeier, SAP Hybris' Founder Carsten Thoma, SevDesk Founders Fabian Silberer & Marco Reinbold, and Gonzalo Manrique.

CTO Daniel Vöckler (left) and CEO Andreas Martin (right)

Flowers Software was created in 2019 by Andreas Martin and Daniel Vöckler as a completely new approach to simplify the complex world of digital business organization with fast, simple, flexible, and automated recurring workflows. During their previous ventures, the founders realized that what kills companies is a lack of oversight and execution excellence.

"I discovered two universal truths about organizations. First, that they are all similarly chaotic - without clear oversight and tools, the right hand typically doesn't know what the left hand is doing. Information exists in silos, and processes that should be driving transparency and performance are so cumbersome that people rarely adhere to them, leading to massive errors and delays. As a result, organizations develop complex processes and use tools that aren't fit for purpose. Second, the business logic of one company is different to that of another company, no matter the size. Many companies struggle to map their processes to the logic of a given software tool and instead want a solution that easily adapts to their needs," said Andreas Martin, CEO and Co-Founder of Flowers Software.

The team developed Flowers Software to help the many SMBs that have been left behind by expensive and complex automation technology which is primarily aimed at the enterprise market. Once workflows have been defined, the software guides everyone in the company through the process steps, making sure everything is correct, transparent and on time.

"We jokingly call Flowers the f*ck-up minimizer. As an example, we estimate that 30% of small businesses wouldn't realize it if they paid a vendor they haven't even done business with. We're creating a composable process layer between systems, assets and teams that orchestrates a company's entire business from A to Z, without a single line of code," said Martin.

The company's "only pay what you use" model has attracted hundreds of customers, including children's hospitals, banks, startups, dentists, construction companies and car dealerships. Flowers captured its initial growth market with invoice approval automation because its flexible solution solves this typical business challenge quickly and easily. However, once customers fully understand the tool's flexibility, they scale up and add additional workflows such as onboarding, holiday requests, budget approvals, contracts, assets and inventory.

"Flowers is changing the game for SMBs in business efficiency, productivity, and profitability with a different approach to workflow creation and automation that is resonating with many customers across industries. With Flowers, companies finally have a software that adapts to the way they work, rather than a software that requires the customer to change. We're impressed by the product and strong sales traction that Andreas, Daniel and the team have already acquired and are excited to support them as they scale to new markets," said Judith Dada, General Partner at La Famiglia VC.

With this new capital, Flowers Software will focus on its go to market strategy in Europe and additional product development. The company is also hiring for software development, customer success, sales & marketing roles.

To learn more or request a demo, visit flowers-software.de & https://www.flowers-software.de/en/

About Flowers Software

Founded in 2019, Flowers Software is an organizational management system that helps companies improve their processes and productivity. Based in Munich, the company has raised a total of $3.8 million in funding from investors such as La Famiglia VC, LEA Partners, Mandat Managementberatung and various angel investors.

About La Famiglia VC

La Famiglia is a European seed stage venture capital fund investing into B2B technology companies that enable or disrupt large industries. Their portfolio includes companies like payroll platform Deel, HR management platform Personio, and digital freight forwarder Forto. More than a regular venture fund, La Famiglia serves as a trusted access platform creating unique mutually beneficial relationships between the old and the new world, enabling real differentiated leverage on capital.

Media kit link

https://drive.google.com/drive/folders/1x0TH2YECPMeMcoiOEUSMgNPY540k2dVj

Media Contact:
Andreas Martin
+49 (0) 89-215536621
pr@flowers-software.de

Photo - https://mma.prnewswire.com/media/1935017/Flowers_Software.jpg
Logo - https://mma.prnewswire.com/media/1911426/Flowers_Software_Logo.jpg

Flowers Software Logo

Cision View original content:https://www.prnewswire.co.uk/news-releases/flowers-software-secures-3-2-million-in-seed-to-bring-enterprise-grade-workflow-automation-to-smbs-301665172.html

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.